First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species

Mesopelagic organisms form huge biomass aggregations, supporting important pelagic trophic webs and several top predators. Although some studies on the occurrence, biology and ecology of these organisms are available, to date there are no investigations on their potential use for anticancer and anti...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Authors: Lauritano, Chiara, Martínez, Kevin A., Battaglia, Pietro, Granata, Antonia, de la Cruz, Mercedes, Cautain, Bastien, Martín, Jesús, Reyes, Fernando, Ianora, Adrianna, Guglielmo, Letterio
Format: Text
Language:English
Published: Nature Publishing Group UK 2020
Subjects:
Eta
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080843/
http://www.ncbi.nlm.nih.gov/pubmed/32188923
https://doi.org/10.1038/s41598-020-61515-z
id ftpubmed:oai:pubmedcentral.nih.gov:7080843
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:7080843 2023-05-15T17:10:42+02:00 First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species Lauritano, Chiara Martínez, Kevin A. Battaglia, Pietro Granata, Antonia de la Cruz, Mercedes Cautain, Bastien Martín, Jesús Reyes, Fernando Ianora, Adrianna Guglielmo, Letterio 2020-03-18 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080843/ http://www.ncbi.nlm.nih.gov/pubmed/32188923 https://doi.org/10.1038/s41598-020-61515-z en eng Nature Publishing Group UK http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080843/ http://www.ncbi.nlm.nih.gov/pubmed/32188923 http://dx.doi.org/10.1038/s41598-020-61515-z © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. CC-BY Article Text 2020 ftpubmed https://doi.org/10.1038/s41598-020-61515-z 2020-03-29T01:31:48Z Mesopelagic organisms form huge biomass aggregations, supporting important pelagic trophic webs and several top predators. Although some studies on the occurrence, biology and ecology of these organisms are available, to date there are no investigations on their potential use for anticancer and antimicrobial biotechnological applications. The aim of this study was to screen extracts of seven mesopelagic species for possible anticancer (Lung cell line A549, skin cell line A2058, liver cell line HepG2, breast cell line MCF7 and pancreas cell line MiaPaca-2) and antibacterial (Gram-negative bacteria Escherichia coli and Klebsiella pneumoniae, the Gram-positive bacteria methicillin resistant/sensitive Staphylococcus aureus, and Mycobacterium tuberculosis) activities. Results showed that only two species were active, the lanternfish Myctophum punctatum and the Mediterranean krill Meganyctiphanes norvegica. In particular, M. punctatum showed strong activity against the A549 and MCF7 cells, while M. norvegica was more active against HepG2 cells. Regarding antibacterial assays, both species were active against methicillin resistant S. aureus. Fractionation and LC/MS dereplication of the fractions showed that the main compounds found in extracts of both species were EPA, DHA and ETA. For some of the detected compounds anticancer and/or antibacterial activity are already known, but this is the first time that such activities have been found for mesopelagic species. Text Meganyctiphanes norvegica PubMed Central (PMC) Eta ENVELOPE(-62.917,-62.917,-64.300,-64.300) Scientific Reports 10 1
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Article
spellingShingle Article
Lauritano, Chiara
Martínez, Kevin A.
Battaglia, Pietro
Granata, Antonia
de la Cruz, Mercedes
Cautain, Bastien
Martín, Jesús
Reyes, Fernando
Ianora, Adrianna
Guglielmo, Letterio
First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species
topic_facet Article
description Mesopelagic organisms form huge biomass aggregations, supporting important pelagic trophic webs and several top predators. Although some studies on the occurrence, biology and ecology of these organisms are available, to date there are no investigations on their potential use for anticancer and antimicrobial biotechnological applications. The aim of this study was to screen extracts of seven mesopelagic species for possible anticancer (Lung cell line A549, skin cell line A2058, liver cell line HepG2, breast cell line MCF7 and pancreas cell line MiaPaca-2) and antibacterial (Gram-negative bacteria Escherichia coli and Klebsiella pneumoniae, the Gram-positive bacteria methicillin resistant/sensitive Staphylococcus aureus, and Mycobacterium tuberculosis) activities. Results showed that only two species were active, the lanternfish Myctophum punctatum and the Mediterranean krill Meganyctiphanes norvegica. In particular, M. punctatum showed strong activity against the A549 and MCF7 cells, while M. norvegica was more active against HepG2 cells. Regarding antibacterial assays, both species were active against methicillin resistant S. aureus. Fractionation and LC/MS dereplication of the fractions showed that the main compounds found in extracts of both species were EPA, DHA and ETA. For some of the detected compounds anticancer and/or antibacterial activity are already known, but this is the first time that such activities have been found for mesopelagic species.
format Text
author Lauritano, Chiara
Martínez, Kevin A.
Battaglia, Pietro
Granata, Antonia
de la Cruz, Mercedes
Cautain, Bastien
Martín, Jesús
Reyes, Fernando
Ianora, Adrianna
Guglielmo, Letterio
author_facet Lauritano, Chiara
Martínez, Kevin A.
Battaglia, Pietro
Granata, Antonia
de la Cruz, Mercedes
Cautain, Bastien
Martín, Jesús
Reyes, Fernando
Ianora, Adrianna
Guglielmo, Letterio
author_sort Lauritano, Chiara
title First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species
title_short First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species
title_full First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species
title_fullStr First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species
title_full_unstemmed First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species
title_sort first evidence of anticancer and antimicrobial activity in mediterranean mesopelagic species
publisher Nature Publishing Group UK
publishDate 2020
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080843/
http://www.ncbi.nlm.nih.gov/pubmed/32188923
https://doi.org/10.1038/s41598-020-61515-z
long_lat ENVELOPE(-62.917,-62.917,-64.300,-64.300)
geographic Eta
geographic_facet Eta
genre Meganyctiphanes norvegica
genre_facet Meganyctiphanes norvegica
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080843/
http://www.ncbi.nlm.nih.gov/pubmed/32188923
http://dx.doi.org/10.1038/s41598-020-61515-z
op_rights © The Author(s) 2020
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
op_rightsnorm CC-BY
op_doi https://doi.org/10.1038/s41598-020-61515-z
container_title Scientific Reports
container_volume 10
container_issue 1
_version_ 1766067358296702976